Save the New Tetracycline Omadacycline (Nuzyra) as a Last Resort

January 2019

You'll see a new, once-daily, IV and PO tetracycline antibiotic, omadacycline (Nuzyra, noo-ZYE-rah)....

Exclusive Subscriber Content

Best in class medication learning
Concise recommendations
Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login

Table of Contents

Iron Consider Expanding Use of Intravenous Iron to More Patients
Delirium Limit Antipsychotics to Patients With Delirium Plus Severe Agitation
Liver Disease Take Special Precautions When Patients With Cirrhosis Undergo Surgery
Venous Thromboembolism Avoid Universal VTE Prophylaxis in Medical Patients
MRSA Use Appropriate MRSA Decolonization Strategies
New Drugs Save the New Tetracycline Omadacycline (Nuzyra) as a Last Resort
Diabetes Consider the CV Benefits of Different SGLT2 Inhibitors
Cardiology Be Ready to Handle Non-Statins During Transitions of Care
Asthma Switch Patients Taking Primatene Mist to Albuterol